COSCIENS Biopharma (CSCI) Selling, General & Administrative Expenses

Annual SGA

$5.52 M
+$2.66 M+92.71%

December 1, 2023

Summary

Performance

1-Year Change

+92.71%

3-Year Change

+118.12%

5-Year Change

+121.97%

15-Year Change

+149.25%

CSCI SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

9.68%
CSCI annual SGA is higher than 9.68% of companies in Healthcare sector

High & Low

All-time High

$5.52 M
CSCI annual SGA is currently at an all-time high

3-Year Low

$2.62 M
CSCI annual SGA is currently +110.75% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
CSCI previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
CSCI next annual earnings announcement has not yet been scheduled

OtherCSCIexpensesmetrics:

Annual Total Expenses

$22.51 M
CSCI annual total expenses is $22.51 million

Annual Operating Expenses

$22.28 M
CSCI annual total operating expenses is $22.28 million

Annual Cost Of Goods Sold

$4.20 M
CSCI annual cost of goods sold is $4.20 million

Annual Interest Expense

$96.60 K
CSCI annual interest expense is $96.60 thousand

Quarterly SGA

$2.99 M
-$52.00 K-1.71%

September 1, 2024

Summary

Performance

3-Month Change

-1.71%

1-Year Change

+67.01%

3-Year Change

+67.01%

5-Year Change

+67.01%

CSCI Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.03%
CSCI quarterly SGA is higher than 26.03% of companies in Healthcare sector

High & Low

All-time High

$3.04 M
CSCI quarterly SGA is currently -1.71% below its historical high of $3.04 million

3-Year Low

$620.20 K
CSCI quarterly SGA is currently +382.43% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CSCI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
CSCI next earnings announcement has not yet been scheduled

OtherCSCIexpensesmetrics:

Quarterly Total Expenses

$6.71 M
CSCI quarterly total expenses is $6.71 million

Quarterly Operating Expenses

$5.79 M
CSCI quarterly total operating expenses is $5.79 million

Quarterly Cost Of Goods Sold

$914.00 K
CSCI quarterly cost of goods sold is $914.00 thousand

Quarterly Interest Expense

$22.00 K
CSCI quarterly interest expense is $22.00 thousand

TTM SGA

$4.19 M
-$11.26 M-72.87%

September 1, 2024

Summary

Performance

3-Month Change

-47.38%

1-Year Change

-25.41%

3-Year Change

-25.41%

5-Year Change

-25.41%

CSCI TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.04%
CSCI TTM SGA is higher than 87.04% of companies in Healthcare sector

High & Low

All-time High

$30.90 M
CSCI TTM SGA is currently -86.43% below its historical high of $30.90 million

3-Year Low

$4.19 M
CSCI TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CSCI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
CSCI next earnings announcement has not yet been scheduled

OtherCSCIexpensesmetrics:

Annual Total Expenses

$22.51 M
CSCI annual total expenses is $22.51 million

Annual Operating Expenses

$22.28 M
CSCI annual total operating expenses is $22.28 million

TTM Cost Of Goods Sold

$4.72 M
CSCI TTM cost of goods sold is $4.72 million

TTM Interest Expense

$49.40 K
CSCI TTM interest expense is $49.40 thousand

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$5.52 M
CSCI annual SGA is $5.52 million

Annual Operating Expenses

$22.28 M
CSCI annual total operating expenses is $22.28 million

Annual Cost Of Goods Sold

$4.20 M
CSCI annual cost of goods sold is $4.20 million

CSCI Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+92.7%+67.0%-25.4%
3 y3 years+118.1%+67.0%-25.4%
5 y5 years+122.0%+67.0%-25.4%

CSCI Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+110.8%-1.7%+382.4%-86.4%at low
5 y5-yearat high+118.1%-1.7%+420.6%-86.4%+4.3%
alltimeall timeat high+1136.3%-1.7%+4412.8%-86.4%+103.3%

COSCIENS Biopharma Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$2.99 M(-1.7%)
$9.48 M(+19.0%)
Jun 2024
-
$3.04 M(+84.1%)
$7.97 M(+29.7%)
Mar 2024
-
$1.65 M(-7.7%)
$6.14 M(+9.3%)
Dec 2023
$5.52 M(+92.7%)
$1.79 M(+21.0%)
$5.62 M(+22.6%)
Sep 2023
-
$1.48 M(+21.3%)
$4.58 M(+22.4%)
Jun 2023
-
$1.22 M(+7.9%)
$3.74 M(+11.4%)
Mar 2023
-
$1.13 M(+50.1%)
$3.36 M(+17.9%)
Dec 2022
$2.87 M(+9.4%)
$753.50 K(+17.7%)
$2.85 M(+4.0%)
Sep 2022
-
$640.00 K(-23.5%)
$2.74 M(+1.3%)
Jun 2022
-
$837.00 K(+35.0%)
$2.71 M(+2.1%)
Mar 2022
-
$620.20 K(-3.8%)
$2.65 M(+1.7%)
Dec 2021
$2.62 M(+3.5%)
$644.40 K(+6.5%)
$2.61 M(-3.2%)
Sep 2021
-
$604.90 K(-22.6%)
$2.69 M(+0.2%)
Jun 2021
-
$781.70 K(+36.0%)
$2.69 M(+5.8%)
Mar 2021
-
$574.70 K(-21.4%)
$2.54 M(-2.7%)
Dec 2020
$2.53 M(-0.5%)
$730.80 K(+21.7%)
$2.61 M(+3.4%)
Sep 2020
-
$600.40 K(-5.5%)
$2.53 M(+1.2%)
Jun 2020
-
$635.10 K(-1.4%)
$2.49 M(-4.1%)
Mar 2020
-
$644.00 K(-0.3%)
$2.60 M(+0.6%)
Dec 2019
$2.54 M(+2.2%)
$645.70 K(+13.4%)
$2.59 M(+4.4%)
Sep 2019
-
$569.40 K(-23.2%)
$2.48 M(-2.2%)
Jun 2019
-
$741.70 K(+17.8%)
$2.53 M(+5.6%)
Mar 2019
-
$629.60 K(+17.5%)
$2.40 M(+1.6%)
Dec 2018
$2.49 M(+12.3%)
$535.80 K(-14.1%)
$2.36 M(-1.6%)
Sep 2018
-
$623.90 K(+2.9%)
$2.40 M(+6.7%)
Jun 2018
-
$606.40 K(+2.5%)
$2.24 M(+3.4%)
Mar 2018
-
$591.40 K(+3.1%)
$2.17 M(-1.9%)
Dec 2017
$2.22 M(+33.9%)
$573.60 K(+21.2%)
$2.21 M(+5.9%)
Sep 2017
-
$473.40 K(-10.9%)
$2.09 M(+3.5%)
Jun 2017
-
$531.60 K(-16.0%)
$2.02 M(+1.0%)
Mar 2017
-
$632.60 K(+40.6%)
$2.00 M(+7.7%)
Dec 2016
$1.65 M(-16.4%)
$449.80 K(+11.8%)
$1.85 M(+5.0%)
Sep 2016
-
$402.30 K(-21.3%)
$1.76 M(+0.8%)
Jun 2016
-
$511.30 K(+4.5%)
$1.75 M(+0.1%)
Mar 2016
-
$489.10 K(+35.6%)
$1.75 M(-7.7%)
Dec 2015
$1.98 M(+9.4%)
$360.80 K(-7.2%)
$1.89 M(-5.8%)
Sep 2015
-
$389.00 K(-23.7%)
$2.01 M(-2.7%)
Jun 2015
-
$509.70 K(-19.7%)
$2.07 M(+3.6%)
Mar 2015
-
$635.00 K(+33.1%)
$2.00 M(+14.4%)
Dec 2014
$1.81 M(+3.9%)
$477.00 K(+7.0%)
$1.74 M(+5.5%)
Sep 2014
-
$445.80 K(+1.8%)
$1.65 M(+3.8%)
Jun 2014
-
$438.00 K(+14.3%)
$1.59 M(-1.3%)
Mar 2014
-
$383.10 K(-0.7%)
$1.61 M(-4.0%)
Dec 2013
$1.74 M(-12.7%)
$385.90 K(+0.0%)
$1.68 M(-6.8%)
Sep 2013
-
$385.80 K(-16.0%)
$1.81 M(-4.5%)
Jun 2013
-
$459.10 K(+1.8%)
$1.89 M(-3.9%)
Mar 2013
-
$451.00 K(-11.4%)
$1.97 M(-0.7%)
Dec 2012
$1.99 M(+32.8%)
$509.30 K(+8.1%)
$1.98 M(+5.0%)
Sep 2012
-
$471.10 K(-12.0%)
$1.89 M(+7.9%)
Jun 2012
-
$535.50 K(+15.3%)
$1.75 M(+7.6%)
Mar 2012
-
$464.40 K(+11.7%)
$1.62 M(+8.0%)
Dec 2011
$1.50 M(+14.9%)
$415.60 K(+25.0%)
$1.50 M(+3.2%)
Sep 2011
-
$332.50 K(-19.3%)
$1.46 M(-0.2%)
Jun 2011
-
$411.80 K(+19.6%)
$1.46 M(+6.0%)
Mar 2011
-
$344.20 K(-6.7%)
$1.38 M(+2.5%)
Dec 2010
$1.31 M
$368.80 K(+9.9%)
$1.34 M(-3.1%)
DateAnnualQuarterlyTTM
Sep 2010
-
$335.70 K(+1.9%)
$1.39 M(+0.6%)
Jun 2010
-
$329.30 K(+5.9%)
$1.38 M(-7.8%)
Mar 2010
-
$311.00 K(-24.6%)
$1.50 M(-9.4%)
Dec 2009
$1.64 M(-29.8%)
$412.20 K(+26.0%)
$1.65 M(+12.4%)
Sep 2009
-
$327.20 K(-26.7%)
$1.47 M(-12.3%)
Jun 2009
-
$446.50 K(-4.2%)
$1.68 M(-7.0%)
Mar 2009
-
$466.20 K(+103.2%)
$1.80 M(-3.4%)
Dec 2008
$2.33 M(+48.6%)
$229.40 K(-57.0%)
$1.87 M(-10.6%)
Sep 2008
-
$533.20 K(-6.8%)
$2.09 M(+3.6%)
Jun 2008
-
$572.30 K(+7.9%)
$2.01 M(+7.6%)
Mar 2008
-
$530.30 K(+17.6%)
$1.87 M(+15.7%)
Dec 2007
$1.57 M(+30.6%)
$450.80 K(-2.0%)
$1.62 M(+10.9%)
Sep 2007
-
$460.20 K(+6.8%)
$1.46 M(+14.0%)
Jun 2007
-
$430.90 K(+55.9%)
$1.28 M(+9.1%)
Mar 2007
-
$276.40 K(-5.0%)
$1.17 M(+1.2%)
Dec 2006
$1.20 M(+17.4%)
$291.10 K(+3.7%)
$1.16 M(+0.1%)
Sep 2006
-
$280.80 K(-13.3%)
$1.16 M(+5.1%)
Jun 2006
-
$323.70 K(+23.4%)
$1.10 M(-7.9%)
Mar 2006
-
$262.40 K(-9.6%)
$1.20 M(+4.6%)
Dec 2005
$1.02 M(+37.8%)
$290.20 K(+29.4%)
$1.14 M(+6.2%)
Sep 2005
-
$224.30 K(-46.4%)
$1.08 M(+2.5%)
Jun 2005
-
$418.50 K(+99.1%)
$1.05 M(+16.2%)
Mar 2005
-
$210.20 K(-5.9%)
$904.10 K(-2.8%)
Dec 2004
$742.10 K(+5.1%)
$223.40 K(+12.6%)
$929.90 K(+2.5%)
Sep 2004
-
$198.40 K(-27.1%)
$906.90 K(-1.1%)
Jun 2004
-
$272.10 K(+15.3%)
$917.10 K(+6.0%)
Mar 2004
-
$236.00 K(+17.8%)
$865.40 K(+11.3%)
Dec 2003
$706.40 K(+35.0%)
$200.40 K(-3.9%)
$777.60 K(+3.1%)
Sep 2003
-
$208.60 K(-5.4%)
$754.20 K(+13.5%)
Jun 2003
-
$220.40 K(+48.7%)
$664.70 K(+14.2%)
Mar 2003
-
$148.20 K(-16.3%)
$582.00 K(+10.4%)
Dec 2002
$523.30 K(+17.1%)
$177.00 K(+48.6%)
$527.30 K(+18.3%)
Sep 2002
-
$119.10 K(-13.5%)
$445.80 K(+5.8%)
Jun 2002
-
$137.70 K(+47.3%)
$421.20 K(-8.3%)
Mar 2002
-
$93.50 K(-2.1%)
$459.20 K(+4.0%)
Dec 2001
$446.90 K(-14.7%)
$95.50 K(+1.1%)
$441.70 K(-19.1%)
Sep 2001
-
$94.50 K(-46.2%)
$545.80 K(-4.4%)
Jun 2001
-
$175.70 K(+131.2%)
$570.70 K(+7.7%)
Mar 2001
-
$76.00 K(-61.9%)
$530.00 K(+1.4%)
Dec 2000
$523.80 K(-2.7%)
$199.60 K(+67.2%)
$522.80 K(-2.3%)
Sep 2000
-
$119.40 K(-11.6%)
$535.10 K(-3.0%)
Jun 2000
-
$135.00 K(+96.2%)
$551.90 K(-0.1%)
Mar 2000
-
$68.80 K(-67.5%)
$552.60 K(+0.5%)
Dec 1999
$538.50 K(-27.5%)
$211.90 K(+55.6%)
$550.10 K(-7.5%)
Sep 1999
-
$136.20 K(+0.4%)
$594.50 K(+0.9%)
Jun 1999
-
$135.70 K(+104.7%)
$589.30 K(-10.4%)
Mar 1999
-
$66.30 K(-74.1%)
$657.80 K(-10.2%)
Dec 1998
$742.60 K(-72.2%)
$256.30 K(+95.6%)
$732.40 K(-37.9%)
Sep 1998
-
$131.00 K(-35.8%)
$1.18 M(-20.5%)
Jun 1998
-
$204.20 K(+44.9%)
$1.48 M(-26.0%)
Mar 1998
-
$140.90 K(-80.0%)
$2.00 M(-24.7%)
Dec 1997
$2.67 M(+102.6%)
$703.50 K(+62.0%)
$2.66 M(+36.0%)
Sep 1997
-
$434.30 K(-40.0%)
$1.96 M(+28.5%)
Jun 1997
-
$724.30 K(-9.1%)
$1.52 M(+90.9%)
Mar 1997
-
$797.20 K
$797.20 K
Dec 1996
$1.32 M
-
-

FAQ

  • What is COSCIENS Biopharma annual SGA?
  • What is the all time high annual SGA for COSCIENS Biopharma?
  • What is COSCIENS Biopharma annual SGA year-on-year change?
  • What is COSCIENS Biopharma quarterly SGA?
  • What is the all time high quarterly SGA for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly SGA year-on-year change?
  • What is COSCIENS Biopharma TTM SGA?
  • What is the all time high TTM SGA for COSCIENS Biopharma?
  • What is COSCIENS Biopharma TTM SGA year-on-year change?

What is COSCIENS Biopharma annual SGA?

The current annual SGA of CSCI is $5.52 M

What is the all time high annual SGA for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual SGA is $5.52 M

What is COSCIENS Biopharma annual SGA year-on-year change?

Over the past year, CSCI annual SGA has changed by +$2.66 M (+92.71%)

What is COSCIENS Biopharma quarterly SGA?

The current quarterly SGA of CSCI is $2.99 M

What is the all time high quarterly SGA for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly SGA is $3.04 M

What is COSCIENS Biopharma quarterly SGA year-on-year change?

Over the past year, CSCI quarterly SGA has changed by +$1.20 M (+67.01%)

What is COSCIENS Biopharma TTM SGA?

The current TTM SGA of CSCI is $4.19 M

What is the all time high TTM SGA for COSCIENS Biopharma?

COSCIENS Biopharma all-time high TTM SGA is $30.90 M

What is COSCIENS Biopharma TTM SGA year-on-year change?

Over the past year, CSCI TTM SGA has changed by -$1.43 M (-25.41%)